- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07342452
Randomisert studie av kombinasjonsbehandling med Sofwave og Sculptra
En prospektiv pilotstudie som sammenligner umiddelbar kombinasjonsbehandling versus sekvensiell behandling ved bruk av injiserbar poly-L-melkesyre og synkron ultralyd parallellstråleteknologi
Evaluation of treatment on the upper arm with Sculptra and Sofwave on the same day versus Sofwave followed by Sculptra 1 month later.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This is a prospective, single site, split-body, intra-individual comparison pilot study. Each subject serves as their own control. 13 subjects will be recruited for a goal of treatment 10 subjects. One upper extremity (proximal medial arm) will be randomized to receive immediate combination therapy with both injectable poly-L-lactic acid (PLLA, Sculptra®) and synchronous ultrasound parallel beam technology (Sofwave™) administered over the same day. The contralateral arm will undergo sequential therapy, with PLLA administered at baseline and synchronous ultrasound parallel beam treatment one month later (Treatment Visit #2, Day 30).
The study employs a randomized, split-body design to minimize inter-patient variability, with blinded investigator assessment of efficacy outcomes through assessment of standardized digital photographs and video of snap test (skin turgor test). taken during the Final Visit (Day 120).
Studietype
Registrering (Antatt)
Fase
- Fase 4
Kontakter og plasseringer
Studiekontakt
- Navn: Molly Wanner, MD
- Telefonnummer: 6176433885
- E-post: mwanner@partners.org
Studer Kontakt Backup
- Navn: Margaret Chou, MD
- E-post: mchou3@mgh.harvard.edu
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02114
- Massachusetts General Hospital
-
Ta kontakt med:
- Margaret Chou, MD
- E-post: mchou3@mgh.harvard.edu
-
Ta kontakt med:
- Molly Wanner, MD
- Telefonnummer: 617-643-3885
- E-post: mwanner@partners.org
-
Hovedetterforsker:
- Molly Wanner, MD
-
Underetterforsker:
- Margaret Chou, MD
-
Underetterforsker:
- Bridget Myers, MD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Male and female subjects ≥ 40 years old
- Able to provide informed consent
- Baseline level of upper arm skin flaccidity and volume loss as defined as type III or greater on the Arm Visual Analog Scale (Arm VAS) for aging
Exclusion Criteria:
- Prior treatment to the arms with a biostimulatory agent, energy-based device, or skin-tightening device within the past year.
- History of dermabrasion or deep peels involving the upper arms within the past year.
- History of prior surgery involving the upper arms.
- History of prior fat reduction procedures within the upper arms.
- History of keloids, hypertrophic scarring, or connective tissue disorders.
- Active dermatologic condition involving the treatment site.
- Active systemic or local infection or wounds at treatment site.
- History of lymphatic drainage problems involving the upper arms.
- Excessive subcutaneous fat in the upper arms as judged per the investigator.
- Use of immunosuppressive or anticoagulant/antiplatelet medications.
- Uncontrolled medical conditions interfering with wound healing or impacting bleeding.
- Use of weight loss medications or supplements within the month before the baseline visit.
- BMI ≥ 30 kg/m².
- Non-stable weight (>5% change) during the month prior to enrollment.
- Uncontrolled or current hormonal imbalance, including thyroid, pituitary, or androgen-related disorders.
- History of malignancy during the past 5 years.
- Implanted devices, such as pacemaker or defibrillator.
- Active pregnancy, recent pregnancy within the past 3 months, planning to become pregnant during the study period, and/or breastfeeding.
- History of heavy smoking during the past 10 years.
- History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study procedures.
- Known allergy to any topical anesthetics or PLLA.
- Presence of metal implants or metallic foreign bodies within the treatment area (upper arms).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Sofwave og Sculptra samme dag
|
parallel beam ultrasound on arm Sculptra injection into arm |
|
Aktiv komparator: Sofwave og Sculptra en måned fra hverandre
|
parallel beam ultrasound on arm Sculptra injection into arm |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
GAIS skin laxity
Tidsramme: From treatment to 3 months after treatment
|
5-graded scale: worse; no change; improved; much improved; or very much improved. |
From treatment to 3 months after treatment
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2025P003217
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .